A HEAD-TO-HEAD COMPARISON OF PEGINTERFERON α-2B TREATMENT REGIMENS IN THE TREATMENT OF CHINESE AND SOUTH-EAST ASIAN PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Fan, Xiaoling [1 ]
Wang, Yuming [2 ]
Luo, Duande [3 ]
Hou, Jinlin [4 ]
Huang, Zhenfei [5 ]
Zhang, Ye [5 ]
Xu, Dao-Zhen [1 ]
Cheng, Jun [1 ]
机构：
[1] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[2] Third Mil Med Univ PLA, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China
[4] Nanfang Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China
[5] MSD China, Dept Med, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
133
引用
收藏
页码：386A / 386A
页数：1
相关论文
共 50 条
  • [1] PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE
    Chan, H. L.
    Ahn, S. H.
    Chang, T. -T.
    Peng, C. -Y.
    Wong, D.
    Coffin, C. S.
    Lim, S. G.
    Chen, P. -J.
    Janssen, H. L.
    Marcellin, P.
    Serfaty, L.
    Zeuzem, S.
    Cohen, D.
    Critelli, L.
    Xu, D.
    Cooney, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S48 - S48
  • [2] Peginterferon α-2b improves liver histology in Chinese patients with HBeAg positive chronic hepatitis B
    Cheng, J.
    Wang, Y. M.
    Hou, J. L.
    Luo, D. D.
    Xie, Q.
    Ning, Q.
    Huang, Z. F.
    Xu, D. Z.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 137 - 137
  • [3] Peginterferon Lambda, a New Potential Therapeutic Option for the Treatment of Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa in Patients with HBeAg-Positive Disease
    Chan, Henry Lik-Yuen
    Ahn, Sang Hoon
    Chang, Ting-Tsung
    Peng, Cheng-Yuan
    Wong, David K.
    Coffin, Carla S.
    Lim, Seng Gee
    Chen, Pei-Jer
    Janssen, Harry L.
    Marcellin, Patrick
    Serfaty, Lawrence
    Zeuzem, Stefan
    Hu, Wenhua
    Critelli, Linda
    Lopez-Talavera, Juan Carlos
    Cooney, Elizabeth L.
    HEPATOLOGY, 2012, 56 (06) : 1525 - 1526
  • [4] Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Cheng, Jun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Mohamed, Rosmawati
    Guan, Richard
    Lee, Tzong-Hsi
    Chang, Wen-Hsiung
    Huang Zhenfei
    Ye, Zhang
    Xu, Daozhen
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (04) : 509 - 516
  • [5] Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
    Chan, Henry L. Y.
    Ahn, Sang Hoon
    Chang, Ting-Tsung
    Peng, Cheng-Yuan
    Wong, David
    Coffin, Carla S.
    Lim, Seng Gee
    Chen, Pei-Jer
    Janssen, Harry L. A.
    Marcellin, Patrick
    Serfaty, Lawrence
    Zeuzem, Stefan
    Cohen, David
    Critelli, Linda
    Xu, Dong
    Wind-Rotolo, Megan
    Cooney, Elizabeth
    JOURNAL OF HEPATOLOGY, 2016, 64 (05) : 1011 - 1019
  • [6] Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine
    Song, K
    Rajvanshi, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (15): : 1630 - 1630
  • [7] Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B
    Wu, Haiqing
    Zhao, Gangde
    Qian, Fangxing
    Liu, Kehui
    Xie, Jingdong
    Zhou, Huijuan
    Xu, Jie
    Xu, Yumin
    Han, Yan
    Xie, Qing
    Wang, Hui
    HEPATOLOGY, 2013, 58 : 642A - 642A
  • [8] Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B
    Wu, Haiqing
    Zhao, Gangde
    Qian, Fangxing
    Liu, Kehui
    Xie, Jingdong
    Zhou, Huijuan
    Xu, Jie
    Xu, Yumin
    Han, Yan
    Xie, Qing
    Wang, Hui
    LIVER INTERNATIONAL, 2015, 35 (02) : 473 - 481
  • [9] HEAD-TO-HEAD COMPARISON OF VIRAL KINETICS OF TELBIVUDINE AND ENTECAVIR IN PATIENTS WITH CHRONIC HEPATITIS B OVER THE FIRST 12 WEEKS OF TREATMENT
    Suh, Dong J.
    Herrmann, Eva
    Zeuzem, Stefan
    Um, Soon ho
    Lee, Han Chu
    Kim, Ju Hyun
    Lee, Young-Sok
    Lopez, Patricia M.
    Avila, Claudio
    HEPATOLOGY, 2008, 48 (04) : 719A - 720A
  • [10] Peginterferon α-2a versus peginterferon α-2b in the treatment of chronic hepatitis C
    Mauss, S
    Berger, F
    Felten, G
    Hueppe, D
    Schmutz, G
    JOURNAL OF HEPATOLOGY, 2005, 42 : 213 - 213
12345